Acadia Healthcare (ACHC) Downgraded to “Sell” at BidaskClub
BidaskClub cut shares of Acadia Healthcare (NASDAQ:ACHC) from a hold rating to a sell rating in a research report sent to investors on Wednesday morning.
A number of other equities research analysts also recently issued reports on ACHC. Zacks Investment Research downgraded Acadia Healthcare from a hold rating to a sell rating in a research report on Monday, October 2nd. Jefferies Group set a $42.00 price objective on Acadia Healthcare and gave the stock a buy rating in a research report on Wednesday, October 25th. Robert W. Baird downgraded Acadia Healthcare from an outperform rating to a neutral rating and lowered their price objective for the stock from $55.00 to $38.00 in a research report on Wednesday, October 25th. BMO Capital Markets began coverage on Acadia Healthcare in a research report on Monday, October 16th. They issued an outperform rating and a $52.00 price objective on the stock. Finally, Mizuho reiterated a neutral rating on shares of Acadia Healthcare in a research report on Monday, October 30th. Two equities research analysts have rated the stock with a sell rating, six have issued a hold rating and eight have given a buy rating to the stock. The company currently has an average rating of Hold and a consensus target price of $44.17.
Shares of Acadia Healthcare (NASDAQ:ACHC) traded up $0.25 during mid-day trading on Wednesday, hitting $34.63. The company had a trading volume of 871,402 shares, compared to its average volume of 1,250,000. The company has a quick ratio of 1.36, a current ratio of 1.36 and a debt-to-equity ratio of 1.30. Acadia Healthcare has a one year low of $26.92 and a one year high of $54.34. The stock has a market capitalization of $3,040.00, a P/E ratio of 17.67, a PEG ratio of 1.18 and a beta of 0.90.
In other Acadia Healthcare news, Director Reeve B. Waud sold 100,000 shares of the firm’s stock in a transaction dated Friday, December 15th. The stock was sold at an average price of $31.80, for a total transaction of $3,180,000.00. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Company insiders own 11.10% of the company’s stock.
Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Zurcher Kantonalbank Zurich Cantonalbank raised its position in Acadia Healthcare by 11.1% during the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,704 shares of the company’s stock valued at $134,000 after purchasing an additional 270 shares in the last quarter. C M Bidwell & Associates Ltd. purchased a new stake in Acadia Healthcare during the second quarter valued at about $205,000. Riverhead Capital Management LLC purchased a new stake in Acadia Healthcare during the second quarter valued at about $209,000. Rathbone Brothers plc purchased a new stake in Acadia Healthcare during the third quarter valued at about $223,000. Finally, SG Americas Securities LLC purchased a new stake in Acadia Healthcare during the second quarter valued at about $280,000.
About Acadia Healthcare
Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.